Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19485
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse,effects/*therapeutic use,Carboplatin/administration & dosage,Cisplatin/administration & dosage,Disease-Free Survival,Drug Administration Schedule,Female,Humans,Ovarian Neoplasms/*drug therapy,Paclitaxel/administration & dosage,Patient Compliance,Prospective Studies,Survival Analysis
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19485
ISSN: 0923-7534
Link: http://www.ncbi.nlm.nih.gov/pubmed/15928071
http://annonc.oxfordjournals.org/content/16/7/1116.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Aravantinos-2005-Paclitaxel plus carb.pdf84.53 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons